EVALUATION OF ANTIPARASITIC, ANTITUBERCULOSIS AND ANTIANGIOGENIC ACTIVITIES OF 3-AMINOQUINOLIN-2-ONE DERIVATIVES

Parasitic infections such as leishmaniasis, trypanosomiasis and malaria have significant impacts in third world countries and are the major reasons of mortality. In order to search a new class of antiprotozoal agent, a series of ten quinolin-2-one derivatives was tested in vitro against the parasite...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Muscia,Gisela C, Bollini,Mariela, Bruno,Ana M, Asís,Silvia E
Lenguaje:English
Publicado: Sociedad Chilena de Química 2006
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-97072006000200005
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0717-97072006000200005
record_format dspace
spelling oai:scielo:S0717-970720060002000052006-06-30EVALUATION OF ANTIPARASITIC, ANTITUBERCULOSIS AND ANTIANGIOGENIC ACTIVITIES OF 3-AMINOQUINOLIN-2-ONE DERIVATIVESMuscia,Gisela CBollini,MarielaBruno,Ana MAsís,Silvia E 3-Aminoquinolin-2-one Derivatives Angiogenesis Plasmodium falciparum Tuberculosis Parasitic infections such as leishmaniasis, trypanosomiasis and malaria have significant impacts in third world countries and are the major reasons of mortality. In order to search a new class of antiprotozoal agent, a series of ten quinolin-2-one derivatives was tested in vitro against the parasites causative of malaria, leishmaniasis, sleeping sickness and Chagas´ disease. In general, these compounds exhibited moderate activity against Plasmodium falciparum and showed no activity against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei. Facing to establish a possible mechanism of antimalarial activity their binding to hemin was assayed. Furthermore, the need of developing new therapeutic strategies for the effective control of tuberculosis prompted us to assay twelve of these compounds against Mycobacterium tuberculosis but they did not demonstrate inhibitory activity. In addition, three terms resulted also structurally related to linomide, a recognized drug against angiogenesis, an interesting target for designing new antineoplastic agents. So these compounds were selected at the National Cancer Institute for angiogenesis testing and they exhibited similar activity to those recently reported for linomide and its analoguesinfo:eu-repo/semantics/openAccessSociedad Chilena de QuímicaJournal of the Chilean Chemical Society v.51 n.2 20062006-06-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-97072006000200005en10.4067/S0717-97072006000200005
institution Scielo Chile
collection Scielo Chile
language English
topic 3-Aminoquinolin-2-one Derivatives
Angiogenesis
Plasmodium falciparum
Tuberculosis
spellingShingle 3-Aminoquinolin-2-one Derivatives
Angiogenesis
Plasmodium falciparum
Tuberculosis
Muscia,Gisela C
Bollini,Mariela
Bruno,Ana M
Asís,Silvia E
EVALUATION OF ANTIPARASITIC, ANTITUBERCULOSIS AND ANTIANGIOGENIC ACTIVITIES OF 3-AMINOQUINOLIN-2-ONE DERIVATIVES
description Parasitic infections such as leishmaniasis, trypanosomiasis and malaria have significant impacts in third world countries and are the major reasons of mortality. In order to search a new class of antiprotozoal agent, a series of ten quinolin-2-one derivatives was tested in vitro against the parasites causative of malaria, leishmaniasis, sleeping sickness and Chagas´ disease. In general, these compounds exhibited moderate activity against Plasmodium falciparum and showed no activity against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei. Facing to establish a possible mechanism of antimalarial activity their binding to hemin was assayed. Furthermore, the need of developing new therapeutic strategies for the effective control of tuberculosis prompted us to assay twelve of these compounds against Mycobacterium tuberculosis but they did not demonstrate inhibitory activity. In addition, three terms resulted also structurally related to linomide, a recognized drug against angiogenesis, an interesting target for designing new antineoplastic agents. So these compounds were selected at the National Cancer Institute for angiogenesis testing and they exhibited similar activity to those recently reported for linomide and its analogues
author Muscia,Gisela C
Bollini,Mariela
Bruno,Ana M
Asís,Silvia E
author_facet Muscia,Gisela C
Bollini,Mariela
Bruno,Ana M
Asís,Silvia E
author_sort Muscia,Gisela C
title EVALUATION OF ANTIPARASITIC, ANTITUBERCULOSIS AND ANTIANGIOGENIC ACTIVITIES OF 3-AMINOQUINOLIN-2-ONE DERIVATIVES
title_short EVALUATION OF ANTIPARASITIC, ANTITUBERCULOSIS AND ANTIANGIOGENIC ACTIVITIES OF 3-AMINOQUINOLIN-2-ONE DERIVATIVES
title_full EVALUATION OF ANTIPARASITIC, ANTITUBERCULOSIS AND ANTIANGIOGENIC ACTIVITIES OF 3-AMINOQUINOLIN-2-ONE DERIVATIVES
title_fullStr EVALUATION OF ANTIPARASITIC, ANTITUBERCULOSIS AND ANTIANGIOGENIC ACTIVITIES OF 3-AMINOQUINOLIN-2-ONE DERIVATIVES
title_full_unstemmed EVALUATION OF ANTIPARASITIC, ANTITUBERCULOSIS AND ANTIANGIOGENIC ACTIVITIES OF 3-AMINOQUINOLIN-2-ONE DERIVATIVES
title_sort evaluation of antiparasitic, antituberculosis and antiangiogenic activities of 3-aminoquinolin-2-one derivatives
publisher Sociedad Chilena de Química
publishDate 2006
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-97072006000200005
work_keys_str_mv AT musciagiselac evaluationofantiparasiticantituberculosisandantiangiogenicactivitiesof3aminoquinolin2onederivatives
AT bollinimariela evaluationofantiparasiticantituberculosisandantiangiogenicactivitiesof3aminoquinolin2onederivatives
AT brunoanam evaluationofantiparasiticantituberculosisandantiangiogenicactivitiesof3aminoquinolin2onederivatives
AT asissilviae evaluationofantiparasiticantituberculosisandantiangiogenicactivitiesof3aminoquinolin2onederivatives
_version_ 1718445359930277888